Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023241 (
Legionella
)
6,990
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The intracellular human pathogen
Legionella
pneumophila translocates multiple proteins in the host cytosol known as effectors, which subvert host cellular processes to create a membrane-bound organelle that supports bacterial replication. It was observed that several
Legionella
effectors encode a prototypical eukaryotic prenylation CAAX motif (where C represents a cysteine residue and A denotes an aliphatic amino acid). These bacterial motifs mediated posttranslational modification of effector proteins resulting in the addition of either a farnesyl or geranylgeranyl isoprenyl lipid moiety to the cysteine residue of the CAAX tetrapeptide. Lipidation enhanced membrane affinity for most
Legionella
CAAX motif proteins and facilitated the localization of these effector proteins to host organelles. Host
farnesyltransferase
and class I geranylgeranyltransferase were both involved in the lipidation of the
Legionella
CAAX motif proteins. Perturbation of the host prenylation machinery during infection adversely affected the remodeling of the
Legionella
-containing vacuole. Thus, these data indicate that
Legionella
utilize the host prenylation machinery to facilitate targeting of effector proteins to membrane-bound organelles during intracellular infection.
...
PMID:Lipidation by the host prenyltransferase machinery facilitates membrane localization of Legionella pneumophila effector proteins. 2081 39